Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude: a Randomized Cross-over Controlled Trial

NCT07517068 is registered in ClinicalTrials.gov with University of California, Riverside as lead sponsor.

NCT NCT07517068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude: a Randomized Cross-over Controlled Trial
Lead sponsor
University of California, Riverside
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 17, 2025
Completion date
December 15, 2026
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mountain sickness (ams), hypoxemia, immune response, inflammation